Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of biosimilars in the treatment of rheumatic diseases.
Dörner T, Strand V, Castañeda-Hernández G, Ferraccioli G, Isaacs JD, Kvien TK, Martin-Mola E, Mittendorf T, Smolen JS, Burmester GR. Dörner T, et al. Among authors: isaacs jd. Ann Rheum Dis. 2013 Mar;72(3):322-8. doi: 10.1136/annrheumdis-2012-202715. Epub 2012 Dec 19. Ann Rheum Dis. 2013. PMID: 23253920 Review.
Immunogenicity of biologic agents in rheumatology.
Strand V, Goncalves J, Isaacs JD. Strand V, et al. Among authors: isaacs jd. Nat Rev Rheumatol. 2021 Feb;17(2):81-97. doi: 10.1038/s41584-020-00540-8. Epub 2020 Dec 14. Nat Rev Rheumatol. 2021. PMID: 33318665 Review.
Clinical trials of biosimilars should become more similar.
Kay J, Isaacs JD. Kay J, et al. Among authors: isaacs jd. Ann Rheum Dis. 2017 Jan;76(1):4-6. doi: 10.1136/annrheumdis-2015-208113. Epub 2016 Aug 25. Ann Rheum Dis. 2017. PMID: 27566795 No abstract available.
Precision medicine: the precision gap in rheumatic disease.
Lin CMA, Cooles FAH, Isaacs JD. Lin CMA, et al. Among authors: isaacs jd. Nat Rev Rheumatol. 2022 Dec;18(12):725-733. doi: 10.1038/s41584-022-00845-w. Epub 2022 Oct 10. Nat Rev Rheumatol. 2022. PMID: 36216923 Review.
366 results